Daisuke Takahari

机构：Gunma University, The Cancer Institute Hospital, Gunma University Hospital, Japanese Foundation For Cancer Research · ORCID：0000-0002-2492-6014

发表论文 355 篇 · 总被引 4748 次 · h-index 32

代表论文

• Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023 (2024 · Gastric Cancer · 被引 25)
• Phase 2 study of trastuzumab deruxtecan as neoadjuvant treatment for HER2-positive gastric and gastroesophageal junction adenocarcinoma (EPOC2003). (2024 · Journal of Clinical Oncology · 被引 13)
• Clinicopathological and prognostic significance of HER2-low expression in advanced gastric cancer: a retrospective observational study (2024 · The Oncologist · 被引 11)
• Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysis (2024 · ESMO Gastrointestinal Oncology · 被引 8)
• Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002 (2023 · World Journal of Surgery · 被引 8)
• Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High) (2025 · Therapeutic Advances in Medical Oncology · 被引 7)